Related Experiment Video

Updated: Jun 25, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Elevated HbA1c level: a risk factor for cardiovascular disease mortality in patients with chronic heart failure?

Kay-Tee Khaw1

  • 1Clinical Gerontology Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 2QQ, UK. kk101@medschl.cam.ac.uk

Nature Clinical Practice. Endocrinology & Metabolism
|February 21, 2009
PubMed

Insights

Higher hemoglobin A1c (HbA1c) levels independently increase the risk of death and worsening heart failure in patients with chronic heart failure. This finding highlights the importance of glycemic control for cardiovascular health.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • The Gerstein et al. study investigated the association between glycated hemoglobin (HbA1c) levels and adverse outcomes in patients with chronic heart failure.
  • Previous research suggests a link between HbA1c and cardiovascular disease (CVD) risk across various patient populations.

Discussion:

  • The study found a significant, independent relationship between elevated HbA1c levels and increased risk of cardiovascular mortality, all-cause mortality, and heart failure exacerbation.
  • A 1% increase in HbA1c was associated with a 10-20% rise in these adverse events.
  • These results reinforce the predictive value of HbA1c for CVD morbidity and mortality.

Key Insights:

  • HbA1c level is a significant independent predictor of adverse cardiovascular and mortality outcomes in chronic heart failure patients.
  • The risk escalates progressively with higher HbA1c levels, indicating a dose-response relationship.
  • Measurement of HbA1c can identify high-risk individuals who may benefit from targeted interventions.

Outlook:

  • Further research is needed to determine if achieving HbA1c levels below 7% specifically reduces cardiovascular events in this population.
  • Understanding the precise role of glycemic control in CVD pathogenesis may unveil novel therapeutic and preventive strategies.
  • This evidence supports incorporating HbA1c monitoring into risk stratification and management plans for heart failure patients.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...